siRNA targeted against amyloid precursor protein impairs synaptic activity in vivo

Neurobiology of Aging

Volumn 27, Issue 12, 2006, Pages 1740-1750

  Herard A S ^a,b   Besret, L ^a   Dubois, A ^a   Dauguet, J ^a   Delzescaux, T ^a   Hantraye, P ^a,b   Bonvento, G ^a   Moya, K L ^a  

^a DIF   (France)

^b Molecular Imaging Research Center   (France)

Author keywords

Axonal transport; Neurodegenerative disorder; Rat; RNA interference; Synaptic transmission; Visual stimulation

Indexed keywords

AMYLOID PRECURSOR PROTEIN; SMALL INTERFERING RNA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE TARGETING; MALE; NERVE ENDING; NERVE FIBER TRANSPORT; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PRIORITY JOURNAL; RAT; SUPERIOR COLLICULUS; SYNAPTIC MEMBRANE; VISUAL STIMULATION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AXONAL TRANSPORT; GENE TARGETING; MALE; NEURAL INHIBITION; PHOTIC STIMULATION; PRESYNAPTIC TERMINALS; RATS; RATS, LONG-EVANS; RETINAL GANGLION CELLS; RNA, MESSENGER; RNA, SMALL INTERFERING; SYNAPSES;

EID: 33749995226     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.10.020     Document Type: Article

References (64)

1. Ashley J., Packard M., Ataman B., and Budnik V. Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dx11/Mint. J Neurosci 25 (2005) 5943-5955
2. Baranes D., Lederfein D., Huang Y.Y., Chen M., Bailey C.H., and Kandel E.R. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21 (1998) 813-825
3. Berardi N., Pizzorusso T., and Maffei L. Extracellular matrix and visual cortical plasticity: freeing the synapse. Neuron 44 (2004) 905-908
4. Binns K.E. The synaptic pharmacology underlying sensory processing in the superior colliculus. Prog Neurobiol 59 (1999) 129-159
5. Bonvento G., Sibson N., and Pellerin L. Does glutamate image your thoughts?. TINS 25 (2002) 359-364
6. Breen K.C., Bruce M., and Anderton B.H. Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. J Neurosci Res 28 (1991) 90-100
7. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
8. Coulson E.J., Paliga K., Beyreuther K., and Masters C.L. What the evolution of the amyloid precursor protein supergene family tells us about its function. Neurochem Int 36 (2000) 175-184
9. Dawson G.R., Seabrook G.R., Zheng H., Smith D.W., Graham S., O'Dowd G., et al. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the β-amyloid precursor protein. Neuroscience 90 (1999) 1-13
10. DeKosky S.T., Scheff S.W., and Styren S.D. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5 (1996) 417-421
11. Dityatev A., and Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat Rev Neurosci 4 (2003) 456-468
12. Eggert S., Paliga K., Soba P., Evin G., Masters C.L., Weidemann A., et al. The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by N-glycosylation. J Biol Chem 279 (2004) 18146-18156
13. Endo R., Murakami S., Masuda Y., Taguchi T., Ohtsuka A., Nishizaki K., et al. The perineuronal proteoglycan surface coat in the adult rat brain, with special reference to its reactions to Gomori's ammoniacal silver. Acta Med Okayama 54 (2000) 111-118
14. + channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature 379 (1996) 74-78
15. Hannon G.J., and Rossi J.J. Unlocking the potential of the human genome with RNA interference. Nature 431 (2004) 371-378
16. Hess D.T., Slater T.M., Wilson M.C., and Skene J.H. The 25 kDa synaptosomal-associated protein SNAP-25 is the major methionine-rich polypeptide in rapid axonal transport and a major substrate for palmitoylation in adult CNS. J Neurosci 12 (1992) 4634-4641
17. Hilbich C., Monning U., Grund C., Masters C.L., and Beyreuther K. Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J Biol Chem 268 (1993) 26571-26577
18. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., and Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414 (2001) 643-648
19. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., et al. APP processing and synaptic function. Neuron 37 (2003) 925-937
20. Kelly B.L., Vassard R., and Ferreira A. β-Amyloid-induced dynamin 1 depletion in hippocampal neuron. A potential mechanism for early cognitive decline in Alzheimer disease. J Biol Chem 280 (2005) 31746-31753
21. 14C]deoxyglucose technique. Proc Natl Acad Sci USA 73 (1976) 4230-4234
22. Koo E.H., Sisodia S.S., Archer D.R., Martin L.J., Weidemann A., Beyreuther K., et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 87 (1990) 1561-1565
23. Logothetis N.K., Pauls J., Augath M., Trinath T., and Oeltermann A. Neuropysiological investigation of the basis of the fMRI signal. Nature 412 (2001) 150-156
24. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155 (1999) 853-862
25. Lyckman A.W., Confaloni A.M., Thinakaran G., Sisodia S.S., and Moya K.L. Post-translational processing and turnover kinetics of presynaptically targeted amyloid precursor superfamily proteins in the central nervous system. J Biol Chem 273 (1998) 11100-11106
26. Lyckman A.W., Moya K.L., Confaloni A., and Jhaveri S. Early postnatal expression of L1 by retinal fibers in the optic tract and synaptic targets of the Syrian hamster. J Comp Neurol 423 (2000) 40-51
27. Masliah E. Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 10 (1995) 509-519
28. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., and Terry R. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 174 (1994) 67-72
29. Mataga N., Mizuguchi Y., and Hensch T.K. Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator. Neuron 44 (2004) 1031-1041
30. McFarlane I., Breen K.C., Di Giamberardino L., and Moya K.L. Inhibition of N-glycan processing alters axonal transport of synaptic glycoproteins in vivo. Neuroreport 11 (2001) 1543-1547
31. McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., et al. Soluble pool of a beta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46 (1999) 860-866
32. Mize R.R., and Butler G.D. Postembedding immunocytochemistry demonstrates directly that both retinal and cortical terminals in the cat superior colliculus are glutamate immunoreactive. J Comp Neurol 371 (1996) 633-648
33. Morin P.J., Abraham C.R., Amaratunga A., Johnson R.J., Huber G., Sandell J.H., et al. Amyloid precursor protein is synthesized by retinal ganglion cells, rapidly transported to the optic nerve plasma membrane and nerve terminals, and metabolized. J Neurochem 61 (1993) 464-473
34. Moya K.L., Benowitz L.I., Jhaveri S., and Schneider G.E. Changes in rapidly transported proteins in developing hamster retinofugal axons. J Neurosci 8 (1988) 4445-4454
35. Moya K.L., Benowitz L.I., Sabel B.A., and Schneider G.E. Changes in rapidly transported proteins associated with development of abnormal projections in the diencephalon. Brain Res 586 (1992) 265-272
36. Moya K.L., Benowitz L.I., Schneider G.E., and Allinquant B. The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis. Dev Biol 161 (1994) 597-603
37. Moya K.L., Confaloni A.M., and Lyckman A.W. Metabolism of a synaptic protein in mature retinal terminals in vivo: implications for Alzheimer's disease. In: Musio C. (Ed). Vision: The Approach of Biophysics and Neurosciences, Series on Biophysics and Biocybernetics (2001), World Scientific, Singapore/New Jersey/London/Hong Kong 89-100
38. Nordstedt C., Gandy S.E., Alafuzoff I., Caporaso G.L., Iverfeldt K., Grebb J.A., et al. β/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. Proc Natl Acad Sci USA 88 (1991) 8910-8914
39. Oray S., Majewska A., and Sur M. Dendritic spine dynamics are regulated by monocular deprivation and extracellular matrix degradation. Neuron 44 (2004) 1021-1030
40. Ourselin S., Roche A., Subsol G., Pennec X., and Ayache N. Reconstructing a 3-D structure from serial histological sections. Image Vis Comput 19 (2001) 25-31
41. Rapoport S.I., Hatanpaa K., Brady D.R., and Chandrasekaran K. Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease. Neurodegeneration 5 (1996) 473-476
42. 18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44 (1979) 127-137
43. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., and Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 22 (2004) 326-330
44. Rivière D., Regis J., Cointepas Y., Papadopoulos-Orfanos D., Cachia A., and Mangin J.F. A freely available Anatomist/BrainVISA package for structural morphometry of the cortical sulci. Proceedings of the 9th HBM, Neuroimage, vol. 19 (2003) 934
45. Rumble R., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320 (1989) 1446-1452
46. Scheff S.W., DeKosky S.T., and Price D.A. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 11 (1990) 29-37
47. Scheff S.W., and Price D.A. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 24 (2003) 1029-1046
48. Schnitzer M.J., and Block S.M. Kinesin hydrolyses one ATP per 8-nm step. Nature 388 (1997) 386-390
49. Schubert D., LaCorbiere M., Saitoh T., and Cole G. Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate. Proc Natl Acad Sci USA 86 (1989) 2066-2069
50. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 (2001) 741-766
51. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 97 (2000) 6037-6042
52. 14C]deoxyglucose method: four years later. Acta Neurol Scand Suppl 72 (1979) 640-649
53. Sokoloff L. Measurement of local cerebral glucose utilization and its relation to local functional activity in the brain. Adv Exp Med Biol 291 (1991) 21-42
54. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307 (2005) 1282-1288
55. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30 (1991) 572-580
56. Thinakaran G., Kitt C.A., Roskams A.J., Slunt H.H., Masliah E., von Koch C., et al. Distribution of an APP homolog, APLP2, in the mouse olfactory system: a potential role for APLP2 in axogenesis. J Neurosci 15 (1995) 6314-6326
57. Toga A.W., and Collins R.C. Metabolic response to optic centers to visual stimuli in the albino rat: anatomical and physiological considerations. J Comp Neurol 199 (1981) 443-464
58. von Koch C.S., Zheng H., Chen H., Trumbauer M., Thinakaran G., van der Ploeg L.H., et al. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol Aging 18 (1997) 661-669
59. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
60. Wang P., Yang G., Mosier D.R., Chang P., Zaidi T., Gong Y.D., et al. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-like protein 2. J Neurosci 25 (2005) 1219-1225
61. Weidemann A., Konig G., Bunke D., Fischer P., Salbaum J.M., Masters C.L., et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57 (1989) 115-126
62. Wu Y.P., Siao C.J., Lu W., Sung T.C., Frohman M.A., Milev P., et al. The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate. J Cell Biol 148 (2000) 1295-1304
63. Zheng H., Jiang M., Trumbauer M.E., Hopkins R., Sirinathsinghji D.J., Stevens K.A., et al. Mice deficient for the amyloid precursor protein gene. Ann NY Acad Sci 777 (1996) 421-426
64. Zheng H., Jiang M., Trumbauer M.E., Sirinathsinghji D.J., Hopkins R., Smith D.W., et al. Beta-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81 (1995) 525-531